期刊文献+

多囊卵巢综合征与心血管疾病的关系 被引量:1

Relationship between polycystic ovary syndrome and cardiovascular diseases
原文传递
导出
摘要 多囊卵巢综合征(PCOS)是最常见的妇科内分泌疾病。近期研究显示,PCOS患者心血管疾病风险明显增加,而且患者在年轻时已存在动脉粥样硬化的早期病变。PCOS患者中存在的胰岛素抵抗、血脂代谢异常、高雄激素血症及肥胖等均会增加其心血管疾病风险。因此对PCOS患者存在的相关心血管疾病危险因素等进行早期评估,并予以相应治疗具有重要作用。 Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women. Patients with PCOS are at higher risk of cardiovascular diseases, and display subclinical evidence of early cardiovascular diseases. Cardiac risk factors associated with PCOS include insulin resistance, dyslipidemia, hyperandrogenemia, hyperinsulinemia, obesity, etc. Early screening and intervention of these risk factors should be addressed to patients with PCOS, and be incorporated into their routine care programs.
出处 《国际内分泌代谢杂志》 2010年第6期380-382,394,共4页 International Journal of Endocrinology and Metabolism
关键词 多囊卵巢综合征 心血管疾病 代谢综合征 血脂紊乱 肥胖 Polycystic ovary syndrome Cardiovascular diseases Metabolic syndrome Dyslipidemia Obesity
  • 相关文献

参考文献28

  • 1Rautio K,Tapanainen JS,Ruokonen A,et al.Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS:A randomized placebo-controlled study.Hum Reprod,2006,21:1400-1407.
  • 2ACOG Committee on Practice Bulletins-Gynecology,ACOG Practice Bulletin No.108:Polycystic ovary syndrome.Obstet Gynecol,2009,114:936-949.
  • 3Christian RC,Dumesie DA,Behrenbcck T,et al.Prevalence and predictors of coronary artery calcification in women with polycysticovary syndrome.J Clin Endocrinol Metab,2003,88:2562-2568.
  • 4Talbott EO,Zborowski JV,Boudreaux MY,et al.The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome.J Clin Endocrinol Metab,2004,89:6061-6067.
  • 5Meyer C,McGrath BP,Teede HJ.Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.J Clin Endocrinol Metab,2005,90:5711-5716.
  • 6Boulman N,Levy Y,Leiba R,et al.Increased C-reactive protein levels in the polyeystic ovary syndromc:A marker of cardiovascular disease.J Clin Endocrinol Metab,2004,89:2160-2165.
  • 7Verit FF.High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.Arch Gynecol Obstet,2010,281:1009-1014.
  • 8Yildiz BO,Haznedaroglu IC,Kirazli S,et al.Global fibrinolytic capacity is decreased in polycystic ovary syndrome,suggesting a prothrombotic state.J Clin Endocrinol Metab,2002,87:3871-3875.
  • 9Cheang KI,Nestler JE,Futterweit W,et al.Risk of cardiovascular events in mothers of women with polyeystic ovary syndrome.Endocr Pract,2008,14:1084-1094.
  • 10Hudecova M,Holte J,Olovsson M,et al.Endothelial function in patients with polycystic ovary syndrome:A long-term follow-up study.Fertil Steril,2010,[Epub ahead of print].

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部